Clinical Trial Update: FT819 in Subjects With B-cell Malignancies [Phase 1]

View source ↗

Summary

This ClinicalTrials.gov entry provides a Phase 1 trial status update for FT819 in B-cell malignancies, indicating the study is ACTIVE_NOT_RECRUITING. The listed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Lymphoma
• Chronic Lymphocytic Leukemia
• Precursor B-cell Acute Lymphoblastic Leukemia

Drugs mentioned

• FT819

Snippet

Sponsor: Fate Therapeutics | Conditions: Lymphoma, B-Cell, Chronic Lymphocytic Leukemia | Phase 1 | Status: ACTIVE_NOT_RECRUITING